Inoviq Ltd has released a press release.
Cancer Vaccine Study Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Inoviq
- Closure of Entitlement Offer and Shortfall
- Rights Offer Document
- Capital Raising Indicative Timetable
- Non-Renounceable Issue
- Pause In Trading
Later from Inoviq
- Response to ASX Price and Volume Query
- U.S. Patent Issued
- R&D Tax Incentive Refund
- European patent validated
- Capital Raising and Board Changes
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq